IncellDx is a pioneering company in the field of single-cell diagnostics, focusing on advancing precision medicine through innovative technologies. Their platform enables the simultaneous analysis of proteomic and genomic biomarkers at the single-cell level, allowing for effective cell classification and alternative diagnoses. This capability is particularly significant for providing diagnostic and prognostic information that can transform patient care. The company offers a range of products, including probes for HPV E6 and E7 mRNA, CMV mRNA, and various antibodies, which are designed to enhance the accuracy and efficiency of diagnostic testing.

The IncellDx product pipeline includes several specialized systems and reagents, such as the incellPREP™ Tissue Single Cell Suspension System and BioINK™ kits, which are tailored for research use. Their commitment to quality is underscored by adherence to regulatory standards, including CE-IVD and FDA certifications, ensuring that their products meet high-quality benchmarks. IncellDx's focus on continuous improvement and regulatory compliance reflects their dedication to delivering reliable diagnostic solutions that support healthcare professionals in managing complex diseases, including chronic conditions like COVID-19.

United States

IncellDx is a molecular diagnostics company dedicated to revolutionizing healthcare one cell at a time. By combining molecular diagnostics with high throughput cellular analysis, we focus on critical life threatening diseases such as COVID-19, HIV/AIDs, lung cancer, breast cancer, bladder cancer, HPV/cervical cancer, head and neck cancer, ovarian cancer, hepatitis, and organ transplant infections.

Our proprietary diagnostic method provides specific molecular details about each and every cell. This technology now made available through IncellDx, is capable of revolutionizing the field of molecular diagnostics, one cell at a time.

IncellDx

Company Details